Vedanta Group company, Hindustan Zinc to invest Rs 12,000 crore for capacity expansion at Debari facility
Vedanta Group subsidiary, Hindustan Zinc, will invest Rs 12,000 crore to expand its metal smelting and refining operations at the Debari, Udaipur, facility. The company said that the investment will go towards setting up new metal smelters with 250 kilo tonnes capacity per annum.
In a statement, the company said the project will be completed in 36 months’ time.
Read MoreShould You Forget Nvidia and Buy This Artificial Intelligence (AI) Stock Right Now?
-
Year to date, Meta Platforms is the best-performing stock within the Magnificent Seven.
-
The company’s plan to automate ad creation on its platforms by 2026 could provide a lucrative new revenue stream for the digital ad giant.
Quick,
2 Top Tech Stocks That Could Help Make You a Millionaire
Building a retirement portfolio that’s worth a million dollars is not an insurmountable task. All it takes is a few decades of consistently adding relatively reasonable amounts of money to a diversified stock portfolio every month.
» Read more about: 2 Top Tech Stocks That Could Help Make You a Millionaire »
Read MoreEquity, gold or real estate: Which asset has grown money the most in 20 years?
When it comes to building wealth, experts always advise investors to stay invested for the long term. But what does this ‘long-term’ mean and deliver? When experts talk about ‘long-term investing’ in the context of wealth building, they mean holding the investment for a period of 5 to 10 years or even longer.
» Read more about: Equity, gold or real estate: Which asset has grown money the most in 20 years? »
Read MoreElite fellowship backed by Wall Street struggles amid diversity backlash
Join FT Edit
Only $4.99 per month
Access to eight surprising articles a day, hand-picked by FT editors. For seamless reading, access content via the FT Edit page on FT.com and receive the FT Edit newsletter.
» Read more about: Elite fellowship backed by Wall Street struggles amid diversity backlash »
Read MoreThe Burst
84.2% of Bill Gates Portfolio In 4 Stocks
If you went to an Ivy League business school, you would probably learn about diversification and efficient markets, and how it’s not possible to beat the market. Why then do so many billionaires violate the tenets of top academics?
In simple terms, when you have an information advantage, or a winning investment thesis,
» Read more about: 84.2% of Bill Gates Portfolio In 4 Stocks »
Read MoreThe Ivy
Down 30%, Is It Time To Buy This Pharma Giant?
Bristol Myers Squibb (BMY) poses something of a conundrum to investors at the moment. On the one hand, the share price has dramatically underperformed the market, leading to concerns that further declines are on the horizon. And on the other hand, the valuation is starting to look really attractive to bargain hunters.
So,
» Read more about: Down 30%, Is It Time To Buy This Pharma Giant? »
Read More